Novo Nordisk A/S NONOF Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S NONOF Financial and Trading Overview
Novo Nordisk A/S stock price | 84.24 USD |
Previous Close | 98.6 USD |
Open | 96.55 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 95.73 - 98.47 USD |
52 Week Range | 64.08 - 108.51 USD |
Volume | 24.85K USD |
Avg. Volume | 27.7K USD |
Market Cap | 432.27B USD |
Beta (5Y Monthly) | 0.194 |
PE Ratio (TTM) | 39.10569 |
EPS (TTM) | 3.12 USD |
Forward Dividend & Yield | 1.03 (1.06%) |
Ex-Dividend Date | August 18, 2023 |
1y Target Est | N/A |
NONOF Valuation Measures
Enterprise Value | 409.62B USD |
Trailing P/E | 39.10569 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.01532 |
Price/Book (mrq) | 4.6314573 |
Enterprise Value/Revenue | 1.91 |
Enterprise Value/EBITDA | 4.092 |
Trading Information
Novo Nordisk A/S Stock Price History
Beta (5Y Monthly) | 0.194 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 108.51 USD |
52 Week Low | 64.08 USD |
50-Day Moving Average | 98.65 USD |
200-Day Moving Average | 87.16 USD |
NONOF Share Statistics
Avg. Volume (3 month) | 27.7K USD |
Avg. Daily Volume (10-Days) | 51.12K USD |
Shares Outstanding | 3.38B |
Float | 3.31B |
Short Ratio | N/A |
% Held by Insiders | 5.97% |
% Held by Institutions | 38.40% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 7.075 |
Trailing Annual Dividend Yield | 7.17% |
5 Year Average Dividend Yield | 156.00% |
Payout Ratio | 0.42310002 |
Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 35.11% |
Operating Margin (ttm) | 45.82% |
Gross Margin | 84.14% |
EBITDA Margin | 46.67% |
Management Effectiveness
Return on Assets (ttm) | 21.57% |
Return on Equity (ttm) | 88.77% |
Income Statement
Revenue (ttm) | 214.49B USD |
Revenue Per Share (ttm) | 47.73 USD |
Quarterly Revenue Growth (yoy) | 28.89% |
Gross Profit (ttm) | 148.51B USD |
EBITDA | 100.11B USD |
Net Income Avi to Common (ttm) | 75.31B USD |
Diluted EPS (ttm) | 2.46 |
Quarterly Earnings Growth (yoy) | 56.00% |
Balance Sheet
Total Cash (mrq) | 47.59B USD |
Total Cash Per Share (mrq) | 10.63 USD |
Total Debt (mrq) | 26.54B USD |
Total Debt/Equity (mrq) | 28.54 USD |
Current Ratio (mrq) | 0.824 |
Book Value Per Share (mrq) | 20.771 |
Cash Flow Statement
Operating Cash Flow (ttm) | 106.46B USD |
Levered Free Cash Flow (ttm) | 63.8B USD |
Profile of Novo Nordisk A/S
Country | United States |
State | N/A |
City | Bagsvaerd |
Address | Novo Alle 1 |
ZIP | 2880 |
Phone | 45 44 44 88 88 |
Website | https://www.novonordisk.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 61412 |
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current NONOF stock price?
Novo Nordisk A/S NONOF stock price today per share is 84.24 USD.
How to purchase Novo Nordisk A/S stock?
You can buy NONOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is NONOF.
Which industry does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S industry is Biotechnology.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 4.53B.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 27.00000000 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 3.12 USD over the trailing 12 months.
Which sector does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S sector is Healthcare.